develop
vaccin
wide
consid
one
import
medic
advanc
centuri
current
method
push
limit
potenti
new
techniqu
need
develop
employ
combat
new
gener
diseas
infect
sever
advantag
dna
vaccin
dna
vaccin
cost
effect
produc
easili
store
highli
specif
multival
natur
mean
could
combin
vaccin
sever
differ
compon
simultan
either
due
low
express
lack
immun
recognit
inject
plasmid
dna
alon
elicit
strong
enough
immun
respons
protect
vaccin
electropor
ep
non
viral
plasmid
dna
deliveri
approach
effect
enhanc
plasmid
express
immun
ep
requir
applic
electr
field
caus
permeabil
cell
membran
permeabil
membran
briefli
contain
pore
allow
larg
molecul
like
dna
enter
cell
initi
studi
evalu
vivo
ep
transgen
deliveri
express
perform
rat
brain
tumor
rat
liver
studi
demonstr
enhanc
deliveri
express
plasmid
dna
ep
mediat
deliveri
success
ep
mediat
dna
deliveri
demonstr
tissu
type
sever
therapeut
prophylact
indic
cancer
therapi
infecti
diseas
wound
heal
metabol
disord
vaccin
recent
sever
clinic
trial
initi
two
clinic
trial
complet
use
ep
one
assess
toler
intramuscular
deliveri
assess
toxic
clinic
util
deliv
intratumor
ep
melanoma
patient
latter
demonstr
safeti
minim
toxic
feasibl
use
ep
clinic
sinc
success
complet
studi
other
current
activ
recruit
five
involv
dna
vaccin
infecti
agent
clinicaltrialsgov
keyword
electropor
initi
vivo
ep
dna
vaccin
studi
evalu
gene
express
immun
stimul
deliveri
plasmid
encod
either
hepat
b
viru
hbv
protein
human
immunodefici
viru
hiv
protein
gag
muscl
result
confirm
increas
humor
respons
hbv
cellular
immun
respons
hiv
gag
ep
compar
inject
io
plasmid
dna
recent
studi
broaden
list
pathogen
ep
success
use
vivo
includ
viral
pathogen
simian
immunodefici
viru
sever
acut
respiratori
syndrom
influenza
west
nile
japanes
enceph
well
hepat
b
c
human
papilloma
viru
ep
deliv
dna
vaccin
express
protein
parasit
infect
plasmodium
falciparum
one
parasit
caus
malaria
well
bacteri
infect
like
bacillu
anthraci
clostridium
botulinum
mycobacterium
tuberculosi
also
demonstr
enhanc
immunogen
result
demonstr
capac
ep
enhanc
gene
deliveri
protein
express
also
abil
stimul
host
immun
respons
wide
varieti
pathogen
current
electr
mediat
dna
vaccin
employ
pain
invas
needl
electrod
insert
muscl
electr
stimul
primari
tissu
use
vivo
ep
muscl
access
highli
vascular
multinucl
express
dna
long
period
time
due
postmitot
natur
tissu
howev
pain
associ
administr
desir
altern
deliveri
site
method
explor
skin
attract
target
vaccin
high
proport
antigen
present
cell
apc
larg
surfac
area
recent
studi
well
work
done
laboratori
demonstr
intraderm
electr
mediat
dna
express
increas
local
system
electrod
develop
skin
ep
includ
calip
plate
tweezer
clip
electrod
well
sever
needl
electrod
develop
electr
mediat
intraderm
dna
vaccin
util
noninvas
multielectrod
array
mea
shown
figur
ep
deliveri
mea
electrod
place
mm
apart
arrang
row
puls
administ
sequenc
util
electrod
time
form
mm
squar
total
squar
puls
appli
pair
two
direct
perpendicular
puls
round
puls
total
puls
yet
model
directli
measur
field
gener
across
treat
area
skin
believ
appli
field
across
smaller
area
mm
facilit
obtain
uniform
field
would
obtain
field
appli
across
entir
treat
area
mm
lab
previous
demonstr
electrod
use
guinea
pig
skin
model
could
significantli
increas
report
gene
activ
condit
requir
optim
express
determin
vcm
ms
addit
consider
establish
mea
deliv
dna
vaccin
choos
appropri
anim
model
guinea
pig
skin
similar
human
skin
thick
morpholog
reason
select
guinea
pig
model
better
evalu
deliveri
approach
util
small
anim
model
skin
similar
human
therefor
goal
studi
evalu
intraderm
mea
ep
deliveri
hepat
b
surfac
antigen
humanlik
skin
model
anim
procedur
conduct
facil
usf
fulli
accredit
associ
assess
accredit
laboratori
anim
care
aaalac
public
health
servic
ph
research
conduct
protocol
approv
institut
anim
care
use
committe
iacuc
univers
south
florida
colleg
medicin
protocol
anim
hous
handl
util
follow
guidelin
unit
state
nation
institut
health
femal
hartley
guinea
pig
g
use
studi
evalu
skin
ep
condit
guinea
pig
hous
univers
south
florida
colleg
medicin
vivarium
rest
one
week
prior
experiment
guinea
pig
anesthet
isofluran
procedur
previou
exposur
hepat
b
viru
known
plasmid
plasmid
use
studi
hbsag
aldevron
fargo
nd
plasmid
encod
surfac
antigen
hepat
b
driven
cmv
promot
guinea
pig
intraderm
inject
mgml
hbsag
two
site
left
flank
mea
ep
perform
vcm
ms
puls
two
group
use
studi
control
group
inject
plasmid
io
inject
plasmid
plu
ep
iep
group
boost
condit
day
guinea
pig
bled
jugular
vein
variou
time
point
day
day
blood
collect
serum
isol
serum
separ
tube
serum
dilut
twofold
start
guinea
pig
treat
describ
hbsag
without
ep
guinea
pig
whose
tissu
collect
plasmid
express
sacrif
hour
one
treatment
skin
sampl
harvest
excis
treatment
site
snap
frozen
guinea
pig
whose
tissu
collect
assess
damag
cell
infiltr
treat
harvest
hour
one
treatment
tissu
snap
frozen
enzym
link
immunosorb
assay
elisa
use
assess
product
antibodi
treatment
perform
per
manufactur
protocol
aldevron
briefli
plate
nunc
coat
hepat
b
surfac
antigen
aldevron
allow
coat
overnight
plate
block
bsa
pbst
hour
serum
sampl
twofold
dilut
block
buffer
ad
plate
hour
goat
antiguinea
pigap
antibodi
ad
dilut
block
buffer
ap
substrat
pnpp
sigma
ad
color
plate
read
nm
patholog
analysi
skin
section
perform
determin
extent
plasmid
express
well
inflamm
tissu
damag
antihbsag
use
detect
plasmid
express
skin
sampl
taken
hour
treatment
frozen
section
place
slide
slide
rehydr
block
bsa
pbst
incub
humidifi
chamber
hr
hrp
conjug
antihbsag
abd
serotec
made
block
buffer
dilut
sampl
counterstain
hematoxylin
eosin
sampl
collect
hour
frozen
section
place
slide
stain
h
e
determin
extent
cellular
infiltrateinflamm
guinea
pig
bled
day
determin
background
optic
densiti
od
od
averag
standard
deviat
ad
determin
posit
od
experiment
serum
sampl
dilut
twofold
start
end
point
titer
calcul
plot
geometr
mean
signific
determin
student
ttest
use
bonferroni
correct
multipl
comparison
first
step
evalu
mea
deliveri
dna
vaccin
humanlik
model
determin
express
level
hbsag
guinea
pig
treat
describ
without
ep
use
mea
hour
deliveri
guinea
pig
euthan
treat
skin
harvest
process
histolog
evalu
express
hbsag
determin
immunohistochemistri
express
hbsag
seen
io
iep
fig
b
howev
increas
stain
observ
iep
sampl
express
contain
within
epidermi
io
anim
compar
iep
anim
express
seen
within
epidermi
dermi
determin
whether
ep
mea
would
recruit
immun
cell
treatment
site
caus
inflamm
guinea
pig
treat
describ
tissu
sampl
harvest
hour
treatment
sampl
stain
h
e
assess
cellular
infiltr
damag
necrosi
treatment
induct
immun
stimul
import
vaccin
gener
limit
dna
vaccin
induct
immun
cell
infiltr
observ
fig
magnif
background
level
fig
infiltr
demonstr
treatment
control
correspond
low
level
cellular
infiltr
purpl
io
sampl
show
slight
increas
infiltr
compar
treatment
fig
contrast
iep
sampl
show
larg
increas
cellular
infiltr
fig
iep
group
contain
primarili
macrophag
multilob
cell
like
activ
neutrophil
magnif
fig
correspond
prolong
inflammatori
immun
respons
edema
seen
sampl
except
treatment
control
appear
increas
due
ep
like
result
inject
plasmid
tissu
sampl
tissu
damag
necrosi
seen
howev
two
ep
deliv
sampl
minim
ulcer
hour
treatment
one
also
necrosi
sampl
show
damag
necrosi
data
shown
gross
evalu
skin
show
differ
io
iep
group
time
fig
complet
visual
recoveri
skin
seen
day
cellular
infiltr
earli
indic
immun
accur
measur
induct
specif
antibodi
gener
hbsag
antihb
measur
elisa
time
guinea
pig
treat
serum
collect
describ
method
show
signific
increas
antibodi
express
three
week
initi
treatment
week
data
collect
independ
experi
n
experi
total
n
io
ep
group
peak
express
group
occur
week
io
group
gmt
iep
anim
fig
fold
increas
io
remain
rel
constant
fold
greatest
fold
increas
io
occur
week
data
demonstr
mea
effect
use
electr
mediat
dna
vaccin
humanlik
skin
model
ep
mea
gener
increas
plasmid
express
well
increas
immun
infiltr
treatment
magnitud
immun
infiltr
greater
ep
group
io
minim
skin
damag
associ
specif
last
signific
level
antibodi
greater
io
first
report
demonstr
use
mea
dna
vaccin
humanlik
skin
model
dna
vaccin
advantag
integr
host
dna
cost
effect
produc
easili
store
highli
specif
tissu
andor
cell
type
made
vaccin
multipl
agent
simultan
skin
ideal
target
dna
vaccin
due
larg
surfac
area
presenc
antigen
present
cell
like
langerhan
dermal
dendrit
cell
special
induct
immun
howev
inject
plasmid
alon
induc
high
enough
immun
respons
protect
ep
one
method
shown
increas
plasmid
express
well
immun
previou
ep
method
involv
pain
penetr
electrod
go
muscl
facilit
deliveri
advanc
made
use
nonpenetr
electrod
calip
plate
electrod
howev
electrod
requir
high
voltag
enhanc
deliveri
therefor
caus
tissu
damag
studi
evalu
nonpenetr
electrod
reduc
gap
width
electrod
mm
therebi
reduc
absolut
voltag
appli
prevent
visibl
tissu
damag
still
increas
plasmid
express
immun
expect
previou
public
ep
mea
enhanc
express
exact
reason
effect
ep
remain
unknown
increas
plasmid
express
least
case
dna
vaccin
play
import
role
recognit
immun
system
ep
shown
adjuv
effect
recruit
immun
cell
site
puls
applic
studi
saw
influx
nucleat
cell
ep
treat
sampl
cell
like
neutrophil
macrophag
base
morpholog
like
combin
ep
mediat
adjuv
effect
increas
plasmid
express
induct
macrophag
polymorphonucl
neutrophil
indic
chronic
inflammatori
respons
percept
prolong
inflamm
typic
neg
case
indic
express
plasmid
present
prolong
period
time
give
immun
respons
enough
time
perform
function
base
earlier
work
would
expect
prolong
express
decreas
approxim
day
therefor
allow
bodi
heal
gener
deleteri
effect
inflamm
find
seem
correl
antibodi
data
increas
presenc
specif
antibodi
measur
time
antibodi
significantli
increas
compar
inject
geometr
mean
titer
rang
peak
week
antibodi
level
remain
elev
drop
week
still
remain
increas
compar
inject
enhanc
intens
humor
immun
ep
mea
correspond
previous
publish
skin
ep
result
one
primari
reason
evalu
deliveri
method
hepat
b
well
character
vaccin
model
publish
studi
report
geometr
mean
titer
conjunct
protect
efficaci
guinea
pig
present
gmt
paper
higher
also
report
protect
level
fold
necessari
level
gmt
like
still
within
protect
rang
without
gener
unnecessari
addit
respons
compar
specif
hepat
b
dna
vaccin
deliv
ep
sever
anim
model
evalu
ep
shown
protect
level
miuml
recent
compar
public
evalu
minim
invas
devic
protect
vaccin
influenza
result
present
neutral
titer
flu
compar
directli
believ
electrod
design
gener
immun
respons
equal
qualiti
without
tissu
penetr
data
repres
demonstr
capabl
mea
increas
plasmid
express
immun
cell
infiltr
inflammatori
respons
well
antibodi
product
week
humanlik
skin
model
inform
present
potenti
new
method
dna
vaccin
may
translat
human
studi
examin
mea
use
dna
vaccin
infecti
agent
